Basic↦Ethics and Laws↦Swiss Law↦Stem Cell Research Act
What is it? Why is it important?
The Federal Stem Cell Research Act (StRA) regulates conditions:
- Under which it is permissible for human embryonic stem cells to be derived from surplus embryos and used for research purposes
- With the purpose to prevent the misuse of surplus embryos and embryotic stem cells
- With the purpose to protect human dignity
The act does not apply to the use of embryonic stem cells for transplantation purposes in clinical studies.
What do I need to do?
When performing stem cell studies, you are required to know and comply with the requirements of the StRA act.
Read the StRA act and its ordinance (SCRO), and based on your study:
- Be familiar with the organisation of the various chapters and sections
- As applicable, tag relevant articles that need to be complied with in your study
Where can I get help?
Your local CTU↧ can support you with experienced staff regarding this topic
Basel, Departement Klinische Forschung, CTU, dkf.unibas.ch
Lugano, Clinical Trials Unit, CTU-EOC, www.ctueoc.ch
Bern, Clinical Trials Unit, CTU, www.ctu.unibe.ch
Geneva, Clinical Research Center, CRC, crc.hug.ch
Lausanne, Clinical Research Center, CRC, www.chuv.ch
St. Gallen, Clinical Trials Unit, CTU, www.kssg.ch
Zürich, Clinical Trials Center, CTC, www.usz.ch
FEDLEX – laws are available online under numbers
- 810.311 SCRO
- 810.31 StRA
StRA – see in particular article
- Art. 1 Subject, purpose and scope